All-oral combination of vinorelbine and capecitabine as first-line treatment in HER2/Neu-negative metastatic breast cancer

被引：0
|
作者：
Hesham Tawfik
Yousri Rostom
Hesham Elghazaly
机构：
[1] Tanta University,Clinical Oncology Department
[2] Alexandria University,Clinical Oncology Department
[3] Ain Shams University,Clinical Oncology Department
来源：
Cancer Chemotherapy and Pharmacology | 2013年 / 71卷
关键词：
Oral therapy; First-line chemotherapy; Metastatic breast cancer; HER2/Neu-negative;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：913 / 919
页数：6
相关论文
共 50 条
  • [31] Oral vinorelbine in combination with trastuzumab as a first-line therapy of metastatic or locally advanced HER2-positive breast cancer
    Fadi Farhat
    Joseph G. Kattan
    Marwan Ghosn
    Cancer Chemotherapy and Pharmacology, 2016, 77 : 1069 - 1077
  • [32] Phase II study of single agent oral vinorelbine as first-line treatment in patients with HER-2 negative metastatic breast cancer
    Mansour, Maged
    Mourad, Cynthia
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 72 (02) : 429 - 435
  • [33] Phase II study of single agent oral vinorelbine as first-line treatment in patients with HER-2 negative metastatic breast cancer
    Maged Mansour
    Cynthia Mourad
    Cancer Chemotherapy and Pharmacology, 2013, 72 : 429 - 435
  • [34] Oral vinorelbine in combination with trastuzumab as a first-line therapy of metastatic or locally advanced HER2-positive breast cancer
    Farhat, Fadi
    Kattan, Joseph G.
    Ghosn, Marwan
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 77 (05) : 1069 - 1077
  • [35] Capecitabine Monotherapy: Review of Studies in First-Line HER-2-Negative Metastatic Breast Cancer
    O'Shaughnessy, Joyce A.
    Kaufmann, Manfred
    Siedentopf, Friederike
    Dalivoust, Philippe
    Debled, Marc
    Robert, Nicholas J.
    Harbeck, Nadia
    ONCOLOGIST, 2012, 17 (04): : 476 - 484
  • [36] The combination of capecitabine and vinorelbine as a first-line or a second-line treatment in inoperable breast cancer patients
    Nakagawa, T.
    Saito, M.
    Kasumi, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [37] Apatinib plus vinorelbine: A novel combination of all-oral regimen in heavily pretreated patients with metastatic HER2-negative breast cancer.
    Yuan, Peng
    Zhu, Anjie
    Yue, Jian
    Xu, Binghe
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [38] Triple combination of oral vinorelbine, capecitabine and trastuzumab as first-line treatment in HER2-positive metastatic breast cancer (MBC): latest results of an international phase II trial
    Chan, A.
    Ganju, V.
    Becquart, D.
    Conte, P. F.
    Petruzelka, L.
    Perrot, O.
    Villanova, G.
    Tubiana-Mathieu, N.
    EJC SUPPLEMENTS, 2007, 5 (04): : 221 - 222
  • [39] Phase II study of vinorelbine and capecitabine as first-line treatment for metastatic breast cancer.
    El-Sadda, Wael
    Halim, Inas Ibraheim Abdel
    Aziz, Mohamed Abdel
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [40] Vinorelbine and capecitabine combination as first-line treatment in patients with metastatic breast cancer: Final results of a multicentric trial in Egypt
    Elghazaly, H.
    Tawfik, H.
    Mahrous, M.
    Meshref, M. M.
    Sakr, A.
    Haddad, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345